Imolamine

DB09284InvestigationalSmall molecule

Imolamine is a compound with a molecular weight of 260.33 g/mol with the formula diethyl[2-{5-imino-3-phenyl-4,5-dihydro-1,2,3-oxadiazol,-4-yl)ethyl]amine. It is developed under the brand name Coremax by Novartis consumer health SA.

Chemical structure of Imolamine
Primary indication
Imolamine is indicated for the treatment of angina pectoris.Curator reviewed
Formula / weight
C14H20N4O · 260.341 g/mol (avg)

Resolves to

Compound
UNIIK5F4RU5VQJCAS318-23-0ChEMBLCHEMBL2104282ChEBI135072PubChem27501KEGGD07159
Clinical / RWD
ATCC01DX09
Structure
InChIKeyMGSPDRWOUCPKNZ-UHFFFAOYSA-NSMILESCCN(CC)CCN1C(=N)ON=C1C1=CC=CC=C1

What you can answer from here — as of August 30, 2026

3Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 5 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Imolamine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In